Advertisement
Screener

Crinetics Pharmaceuticals, Inc. (CRNX) Operating Expenses

2.8 / 5 stars · 68/120 Roast Me

Crinetics Pharmaceuticals, Inc. Operating Expenses

Crinetics Pharmaceuticals, Inc. (CRNX) reported Operating Expenses of $142.73 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:OperatingExpenses · last filed 2025-11-06

  • Crinetics Pharmaceuticals, Inc. operating expenses for the quarter ending 2025-09-30 was $142.73M, a 62.57% increase year-over-year.
  • Crinetics Pharmaceuticals, Inc. operating expenses for the quarter ending 2025-06-30 was $130.14M, a 56.46% increase year-over-year.
  • Crinetics Pharmaceuticals, Inc. operating expenses for the quarter ending 2025-03-31 was $111.77M, a 50.69% increase year-over-year.
  • Crinetics Pharmaceuticals, Inc. operating expenses for the quarter ending 2024-12-31 was $94.75M, a 51.21% increase year-over-year.
  • Crinetics Pharmaceuticals, Inc. operating expenses for fiscal 2024 was $339.89M, a 49.98% increase from fiscal 2023.
  • Crinetics Pharmaceuticals, Inc. operating expenses for fiscal 2023 was $226.62M, a 31.28% increase from fiscal 2022.
  • Crinetics Pharmaceuticals, Inc. operating expenses for fiscal 2022 was $172.62M, a 58.69% increase from fiscal 2021.
  • Crinetics Pharmaceuticals, Inc. operating expenses for fiscal 2021 was $108.78M, a 44.99% increase from fiscal 2020.
Period endOperating Expenses 3 monthOperating Expenses 6 monthOperating Expenses 9 monthOperating Expenses 12 month
2025-09-30$142.73M
10-Q · filed 2025-11-06
$272.87M
derived: sum of 2 quarters · filed 2025-11-06
$384.64M
10-Q · filed 2025-11-06
$479.38M
derived: sum of 4 quarters · filed 2025-11-06
2025-06-30$130.14M
10-Q · filed 2025-08-07
$241.91M
10-Q · filed 2025-08-07
$336.65M
derived: sum of 3 quarters · filed 2025-08-07
$424.45M
derived: sum of 4 quarters · filed 2025-11-06
2025-03-31$111.77M
10-Q · filed 2025-05-08
$206.51M
derived: sum of 2 quarters · filed 2025-05-08
$294.31M
derived: sum of 3 quarters · filed 2025-11-06
$377.49M
derived: sum of 4 quarters · filed 2025-11-06
2024-12-31$94.75M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
$182.54M
derived: sum of 2 quarters · filed 2025-11-06
$265.72M
derived: sum of 3 quarters · filed 2025-11-06
$339.89M
10-K · filed 2025-02-27
2024-09-30$87.80M
10-Q · filed 2025-11-06
$170.98M
derived: sum of 2 quarters · filed 2025-11-06
$245.15M
10-Q · filed 2025-11-06
$307.81M
derived: sum of 4 quarters · filed 2025-11-06
2024-06-30$83.18M
10-Q · filed 2025-08-07
$157.35M
10-Q · filed 2025-08-07
$220.01M
derived: sum of 3 quarters · filed 2025-08-07
$279.33M
derived: sum of 4 quarters · filed 2025-08-07
2024-03-31$74.17M
10-Q · filed 2025-05-08
$136.83M
derived: sum of 2 quarters · filed 2025-05-08
$196.15M
derived: sum of 3 quarters · filed 2025-05-08
$250.13M
derived: sum of 4 quarters · filed 2025-05-08
2023-12-31$62.66M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
$121.98M
derived: sum of 2 quarters · filed 2025-02-27
$175.96M
derived: sum of 3 quarters · filed 2025-02-27
$226.62M
10-K · filed 2025-02-27
2023-09-30$59.32M
10-Q · filed 2024-11-12
$113.31M
derived: sum of 2 quarters · filed 2024-11-12
$163.96M
10-Q · filed 2024-11-12
$212.23M
derived: sum of 4 quarters · filed 2025-02-27
2023-06-30$53.98M
10-Q · filed 2024-08-08
$104.64M
10-Q · filed 2024-08-08
$152.91M
derived: sum of 3 quarters · filed 2025-02-27
$196.82M
derived: sum of 4 quarters · filed 2025-02-27
2023-03-31$50.66M
10-Q · filed 2024-05-09
$98.92M
derived: sum of 2 quarters · filed 2025-02-27
$142.83M
derived: sum of 3 quarters · filed 2025-02-27
$186.32M
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31$48.27M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
$92.18M
derived: sum of 2 quarters · filed 2025-02-27
$135.66M
derived: sum of 3 quarters · filed 2025-02-27
$172.62M
10-K · filed 2025-02-27
2022-09-30$43.91M
10-Q · filed 2023-11-07
$87.40M
derived: sum of 2 quarters · filed 2023-11-07
$124.35M
10-Q · filed 2023-11-07
$156.32M
derived: sum of 4 quarters · filed 2024-02-28
2022-06-30$43.48M
10-Q · filed 2023-08-08
$80.44M
10-Q · filed 2023-08-08
$112.41M
derived: sum of 3 quarters · filed 2024-02-28
$140.22M
derived: sum of 4 quarters · filed 2024-02-28
2022-03-31$36.96M
10-Q · filed 2023-05-09
$68.92M
derived: sum of 2 quarters · filed 2024-02-28
$96.73M
derived: sum of 3 quarters · filed 2024-02-28
$122.82M
derived: sum of 4 quarters · filed 2024-02-28
2021-12-31$31.97M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28
$59.77M
derived: sum of 2 quarters · filed 2024-02-28
$85.86M
derived: sum of 3 quarters · filed 2024-02-28
$108.78M
10-K · filed 2024-02-28
2021-09-30$27.81M
10-Q · filed 2022-11-14
$53.90M
derived: sum of 2 quarters · filed 2022-11-14
$76.81M
10-Q · filed 2022-11-14
$98.61M
derived: sum of 4 quarters · filed 2023-02-28
2021-06-30$26.09M
10-Q · filed 2022-08-12
$49.01M
10-Q · filed 2022-08-12
$70.80M
derived: sum of 3 quarters · filed 2023-02-28
$89.25M
derived: sum of 4 quarters · filed 2023-02-28
2021-03-31$22.92M
10-Q · filed 2022-05-12
$44.71M
derived: sum of 2 quarters · filed 2023-02-28
$63.16M
derived: sum of 3 quarters · filed 2023-02-28
$80.09M
derived: sum of 4 quarters · filed 2023-02-28
2020-12-31$21.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
$40.24M
derived: sum of 2 quarters · filed 2023-02-28
$57.17M
derived: sum of 3 quarters · filed 2023-02-28
$75.02M
10-K · filed 2023-02-28
2020-09-30$18.45M
10-Q · filed 2021-11-05
$35.38M
derived: sum of 2 quarters · filed 2021-11-05
$53.23M
10-Q · filed 2021-11-05
$68.77M
derived: sum of 4 quarters · filed 2021-11-05
2020-06-30$16.93M
10-Q · filed 2021-08-10
$34.78M
10-Q · filed 2021-08-10
$50.32M
derived: sum of 3 quarters · filed 2021-08-10
$66.05M
derived: sum of 4 quarters · filed 2021-08-10
2020-03-31$17.85M
10-Q · filed 2021-05-06
$33.39M
derived: sum of 2 quarters · filed 2021-05-06
$49.12M
derived: sum of 3 quarters · filed 2021-05-06
$62.47M
derived: sum of 4 quarters · filed 2021-05-06
2019-12-31$15.54M
10-K · filed 2020-03-09
$31.27M
derived: sum of 2 quarters · filed 2020-11-06
$44.61M
derived: sum of 3 quarters · filed 2020-11-06
$55.02M
10-K · filed 2022-03-30
2019-09-30$15.73M
10-Q · filed 2020-11-06
$29.08M
derived: sum of 2 quarters · filed 2020-11-06
$39.49M
10-Q · filed 2020-11-06
$49.70M
derived: sum of 4 quarters · filed 2020-11-06
2019-06-30$13.35M
10-Q · filed 2020-08-07
$23.76M
10-Q · filed 2020-08-07
$33.97M
derived: sum of 3 quarters · filed 2020-08-07
$42.59M
derived: sum of 4 quarters · filed 2020-08-07
2019-03-31$10.41M
10-Q · filed 2020-05-08
$20.62M
derived: sum of 2 quarters · filed 2020-05-08
$29.24M
derived: sum of 3 quarters · filed 2020-05-08
$35.58M
derived: sum of 4 quarters · filed 2020-05-08
2018-12-31$10.21M
10-K · filed 2020-03-09
$18.83M
derived: sum of 2 quarters · filed 2020-03-09
$25.17M
derived: sum of 3 quarters · filed 2020-03-09
$31.14M
10-K · filed 2021-03-30
2018-09-30$8.62M
10-K · filed 2020-03-09
$14.96M
derived: sum of 2 quarters · filed 2020-03-09
$20.93M
10-Q · filed 2019-11-12
$23.95M
derived: sum of 4 quarters · filed 2020-03-09
2018-06-30$6.34M
10-K · filed 2020-03-09
$12.31M
10-Q · filed 2019-08-13
$15.34M
derived: sum of 3 quarters · filed 2020-03-09
$18.35M
derived: sum of 4 quarters · filed 2020-03-09
2018-03-31$5.97M
10-K · filed 2020-03-09
$9.00M
derived: sum of 2 quarters · filed 2020-03-09
$12.01M
derived: sum of 3 quarters · filed 2020-03-09
$14.49M
derived: sum of 4 quarters · filed 2020-03-09
2017-12-31$3.03M
10-K · filed 2019-03-13
$6.04M
derived: sum of 2 quarters · filed 2019-03-13
$8.52M
derived: sum of 3 quarters · filed 2019-03-13
$11.17M
10-K · filed 2020-03-09
2017-09-30$3.01M
10-K · filed 2019-03-13
$5.49M
derived: sum of 2 quarters · filed 2019-03-13
$8.14M
10-Q · filed 2018-11-13
2017-06-30$2.48M
10-K · filed 2019-03-13
$5.13M
10-Q · filed 2018-08-30
2017-03-31$2.65M
10-K · filed 2019-03-13
2016-12-31$6.63M
10-K · filed 2019-03-13